Objective Previous research indicates that patients with severe symptoms of depression or
anxiety are prone toward the development of dyslipidemia and abdominal obesity. We …

Objective: To investigate alternative hypothetical models that could clarify the relationship
between depressive symptoms and serum cholesterol fractions, ie, high-density lipoprotein …

Context Depression has been hypothesized to result in abdominal obesity through the
accumulation of visceral fat. No large study has tested this hypothesis longitudinally …

Background Depression, metabolic disturbances and inflammation have been linked to
cardiovascular disease and mortality. Low levels of high-density lipoprotein cholesterol …

Objective Recent evidence suggests that naturally occurring low cholesterol concentrations
(< 4.14 mmol/liter) are associated with depression as well as poor psychological health. For …

BACKGROUND: Dyslipidemia and obesity have been observed in persons with severe
anxiety or depression, and in tricyclic antidepressant (TCA) users. This likely contributes to …

Background: Obesity is associated with an increased risk of developing a variety of chronic
diseases, most of which are associated with psychiatric disorders. We examined the …

Aim: Abundant evidence suggests that depression is a risk factor for cardiovascular disease
and metabolic syndrome. Systemic low-grade inflammation and evolving abdominal obesity …

BACKGROUND: Treatment guidelines for lipids have become increasingly more aggressive.
However, naturally low or therapeutically reduced cholesterol levels may be associated with …

Objective: There is evidence of more obesity among persons with depressive and
depressive and anxiety disorders. However, the nature and the underlying mechanisms of …